Turkyilmaz S, Ulusahin M, Celebi B, Cekic A B, Mungan S, Kucuktulu U, Tasdelen A, Guner A, Cinel A
Department of General Surgery, Farabi Hospital, Karadeniz Technical University, Trabzon, Turkey.
Department of General Surgery, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Trabzon, Turkey.
Cytopathology. 2017 Oct;28(5):391-399. doi: 10.1111/cyt.12438. Epub 2017 Jul 17.
The objective of the present study was to determine the malignancy risk for nodules categorised as atypia or follicular lesions of undetermined significance atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) and to investigate the predictors of malignancy.
All nodules diagnosed as AUS/FLUS on fine needle aspiration (FNAs) performed between January 2011 and December 2015 were retrospectively reviewed. Clinical data, ultrasonographic features, follow-up data and the final pathological results were recorded. After further exclusion, only nodules that underwent surgical excision were included in the final analysis. The malignancy rate and the range of malignancy rates were calculated. Clinical and ultrasound features were examined to determine the predictors of malignancy.
During the study period, FNA was performed on 9938 nodules, and 1019 (10.2%) nodules were diagnosed as AUS/FLUS. After further exclusion, 976 nodules were evaluated. After the initial diagnosis of AUS/FLUS, 139 (14.2%) patients underwent surgery, 518 (53.1%) had repeated FNAs. A total of 305 (31%) had undergone surgical excision at different time points. For surgically confirmed nodules, the malignancy rate after the initial FNA was 34.5% (the lower and upper thresholds for the malignancy rate were 19.3% and 66.3%, respectively), and 37.9% after the repeated FNA. No ultrasound feature was determined as a predictor, whereas age (>55 years) was a predictor for malignancy.
The overall malignancy rate for nodules diagnosed as AUS/FLUS and the malignancy rate for nodules that underwent repeated FNA after AUS/FLUS were higher than the expected malignancy rates of the National Cancer Institute. It is, therefore, suggested that the current recommendations should be reconsidered.
本研究的目的是确定分类为非典型性或意义不明确的滤泡性病变(AUS/FLUS)的结节的恶性风险,并研究恶性肿瘤的预测因素。
回顾性分析2011年1月至2015年12月期间通过细针穿刺活检(FNA)诊断为AUS/FLUS的所有结节。记录临床数据、超声特征、随访数据和最终病理结果。经过进一步排除后,最终分析仅纳入接受手术切除的结节。计算恶性率及恶性率范围。检查临床和超声特征以确定恶性肿瘤的预测因素。
在研究期间,对9938个结节进行了FNA,其中1019个(10.2%)结节被诊断为AUS/FLUS。进一步排除后,对976个结节进行了评估。在初步诊断为AUS/FLUS后,139例(14.2%)患者接受了手术,518例(53.1%)进行了重复FNA。共有305例(31%)在不同时间点接受了手术切除。对于手术确诊的结节,初次FNA后的恶性率为34.5%(恶性率的下限和上限分别为19.3%和66.3%),重复FNA后为37.9%。未确定任何超声特征为预测因素,而年龄(>55岁)是恶性肿瘤的预测因素。
诊断为AUS/FLUS的结节的总体恶性率以及AUS/FLUS后接受重复FNA的结节的恶性率高于美国国立癌症研究所预期的恶性率。因此,建议重新考虑当前的建议。